Nyxoah S.A. (NYXH)
NASDAQ: NYXH
· Real-Time Price · USD
5.70
-0.18 (-3.06%)
At close: Sep 04, 2025, 3:00 PM
-3.06% (1D)
| Bid | 5.69 |
| Market Cap | 213.35M |
| Revenue (ttm) | 4.93M |
| Net Income (ttm) | -77.2M |
| EPS (ttm) | -2.48 |
| PE Ratio (ttm) | -2.3 |
| Forward PE | -2.65 |
| Analyst | Buy |
| Ask | 5.78 |
| Volume | 74,139 |
| Avg. Volume (20D) | 82,519 |
| Open | 6.00 |
| Previous Close | 5.88 |
| Day's Range | 5.60 - 6.00 |
| 52-Week Range | 5.55 - 11.87 |
| Beta | 0.65 |
About NYXH
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NYXH
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NYXH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Nyxoah S.A. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
-1.07%
Nyxoah shares are trading higher after the company...
Unlock content with
Pro Subscription
4 months ago
+6.13%
Nyxoah shares are trading higher after the company announced it's nearing FDA approval for Genio System. Additionally, HC Wainwright & Co. reiterated a Buy rating on the stock.
